65060
|
Haemoglobin, erythrocyte sedimentation rate, blood viscosity — 1 or more tests
|
7.90
|
65066
|
Examination of:
(a) a blood film by special stains to demonstrate Heinz bodies, parasites or iron; or
|
10.45
|
|
(b) a blood film by enzyme cytochemistry for neutrophil alkaline phosphatase, alpha naphthyl acetate esterase or chloroacetate esterase; or
(c) a blood film using any other special staining methods including periodic acid Schiff and Sudan Black; or
(d) a urinary sediment for haemosiderin;
including a service described in item 65072
|
|
65070
|
Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and manual or instrument generated differential count (not being a service where haemoglobin only is requested) — 1 or more instrument generated set of results from a single sample and (if performed):
(a) a morphological assessment of a blood film; and
(b) any service in item 65060 or 65072
|
17.05
|
65072
|
Examination for reticulocytes including a reticulocyte count by any method — 1 or more tests
|
10.25
|
65075
|
Haemolysis or metabolic enzymes — assessment by 1 or more of the following tests:
(a) erythrocyte autohaemolysis test;
(b) erythrocyte osmotic fragility test;
(c) sugar water test;
(d) G 6 P D (qualitative or quantitative) test;
(e) pyruvate kinase (qualitative or quantitative) test;
(f) acid haemolysis test;
|
52.30
|
|
(g) quantitation of muramidase in serum or urine;
(h) Donath Landsteiner antibody test;
(i) other erythrocyte metabolic enzyme tests
|
90.80
|
65078
|
Tests for the diagnosis of thalassaemia consisting of haemoglobin electrophoresis or chromatography and at least 2 of:
(a) examination for HbH; or
(b) quantitation of HbA2; or
|
90.80
|
|
(c) quantitation of HbF;
including (if performed) any service described in item 65060 or 65070
|
|
65079
|
A test described in item 65078 if rendered by a receiving APP — 1 or more tests
|
90.80
|
65081
|
Tests for the investigation of haemoglobinopathy consisting of haemoglobin electrophoresis or chromatography and at least 1 of:
(a) heat denaturation test; or
|
97.25
|
|
(b) isopropanol precipitation test; or
(c) tests for the presence of haemoglobin S; or
(d) quantitation of any haemoglobin fraction (including S, C, D, E);
including (if performed) any service described in item 65060, 65070 or 65078
|
|
65082
|
A test described in item 65081 if rendered by a receiving APP — 1 or more tests
|
97.25
|
65084
|
Bone marrow trephine biopsy — histopathological examination of sections of bone marrow and examination of aspirated material (including clot sections where necessary), including (if performed) any test described in item 65060, 65066 or 65070
|
166.95
|
65087
|
Bone marrow — examination of aspirated material (including clot sections where necessary), including (if performed) any test described in item 65060, 65066 or 65070
|
83.65
|
65090
|
Blood grouping (including back grouping if performed) — ABO and Rh (D antigen)
|
11.20
|
65093
|
Blood grouping — Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system — 1 or more systems, including item 65090 (if performed)
|
22.15
|
65096
|
Blood grouping (including back grouping if performed), and examination of serum for Rh and other blood group antibodies, including:
(a) identification and quantitation of any antibodies detected; and
(b) (if performed) any test described in item 65060 or 65070
|
41.30
|
65099
|
Compatibility tests by crossmatch — all tests performed on any 1 day for up to 6 units, including:
(a) all grouping checks of the patient and donor; and
(b) examination for antibodies and, if necessary, identification of any antibodies detected; and
(c) (if performed) any tests described in item 65060, 65070, 65090 or 65096
|
109.65
|
65102
|
Compatibility tests by crossmatch — all tests performed on any 1 day in excess of 6 units, including:
(a) all grouping checks of the patient and donor; and
(b) examination for antibodies and, if necessary, identification of any antibodies detected; and
|
165.70
|
|
(c) (if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105
|
|
65105
|
Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion — all tests performed on any 1 day for up to 6 units, including:
(a) all grouping checks of the patient and donor; and
(b) examination for antibodies and, if necessary, identification of any antibodies detected; and
|
109.65
|
|
(c) (if performed) any tests described in item 65060, 65070, 65090 or 65096
|
|
65108
|
Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion — all tests performed on any 1 day in excess of 6 units, including:
(a) all grouping checks of the patient and donor; and
(b) examination for antibodies and, if necessary, identification of any antibodies detected; and
(c) (if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105
|
165.70
|
65109
|
Release of fresh frozen plasma or cryoprecipitate for the use in a patient for the correction of a coagulopathy — 1 release
|
13.00
|
65110
|
Release of compatible fresh platelets for the use in a patient for platelet support as prophylaxis to minimize bleeding or during active bleeding — 1 release
|
13.00
|
65111
|
Examination of serum for blood group antibodies (including identification and, if necessary, quantitation of any antibodies detected)
|
23.35
|
65114
|
1 or more of the following tests:
(a) direct Coombs (antiglobulin) test;
(b) qualitative or quantitative test for cold agglutinins or heterophil antibodies
|
9.15
|
65117
|
1 or more of the following tests:
(a) spectroscopic examination of blood for chemically altered haemoglobins;
(b) detection of methaemalbumin (Schumm’s test)
|
20.40
|
65120
|
Prothrombin time (including INR where appropriate), activated partial thromboplastin time, thrombin time (including test for the presence of heparin), test for factor XIII deficiency (qualitative), Echis test, Stypven test, reptilase time, fibrinogen, or 1 of fibrinogen degradation products, fibrin monomer or D dimer — 1 test
|
13.80
|
65123
|
2 tests described in item 65120
|
20.50
|
65126
|
3 tests described in item 65120
|
28.05
|
65129
|
4 or more tests described in item 65120
|
35.75
|
65137
|
A test for the presence of lupus anticoagulant, not being a service connected with a service to which item 65175, 65176, 65177, 65178 or 65179 applies
|
25.50
|
65142
|
Confirmation or clarification of an abnormal or indeterminate result of a test mentioned in item 65175, by testing a specimen collected on a different day — 1 or more tests
|
25.50
|
65144
|
Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or other substances; or heparin, low molecular weight heparins, heparinoid or other drugs — 1 or more tests
|
56.95
|
65147
|
Quantitation of anti Xa activity when monitoring is required for a patient receiving a low molecular weight heparin or heparinoid — 1 test
|
38.15
|
65150
|
Quantitation of von Willebrand factor antigen, von Willebrand factor activity (ristocetin cofactor assay), von Willebrand factor collagen binding activity, factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, circulating coagulation factor inhibitors other than by Bethesda assay — 1 test
|
71.40
|
65153
|
2 tests described in item 65150
|
142.80
|
65156
|
3 or more tests described in item 65150
|
214.20
|
65157
|
A test described in item 65150, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP — 1 test
|
71.40
|
65158
|
A test described in item 65150, if rendered by a receiving APP, where 1 or more tests in the item have been rendered by the referring APP — 1 test
|
71.40
|
65159
|
Quantitation of circulating coagulation factor inhibitors by Bethesda assay — 1 test
|
71.40
|
65162
|
Examination of a maternal blood film for the presence of fetal red blood cells (Kleihauer test)
|
10.50
|
65165
|
Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell antigens using flow cytometric methods including (if performed) any test described in item 65070 or 65162
|
34.70
|
65166
|
A test described in item 65165 if rendered by a receiving APP — 1 or more tests
|
34.70
|
65171
|
A test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency or activated protein C resistance in a first degree relative of a person who has a proven deficiency mentioned in this item — 1 or more tests
|
25.50
|
65175
|
A test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance, if the request for the test specifically identifies that the patient has a history of venous thromboembolism — quantitation by 1 or more techniques — 1 test
|
25.50
|
65176
|
2 tests described in item 65175
|
49.00
|
65177
|
3 tests described in item 65175
|
72.45
|
65178
|
4 tests described in item 65175
|
95.85
|
65179
|
5 tests described in item 65175
|
119.30
|
65180
|
A test described in item 65175, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP — 1 test
|
25.50
|
65181
|
A test described in item 65175, if rendered by a receiving APP, where 1 or more tests in the item have been rendered by the referring APP — 1 test
|
23.45
|
